When the levee doesn't break: A novel role of β2- glycoprotein I to protect against congenital heart block

Arthritis and Rheumatism

Volumn 60, Issue 3, 2009, Pages 636-638

  Clancy, Robert M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; CONGENITAL HEART BLOCK; EDITORIAL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; HEART BLOCK; HUMANS; MYOCYTES, CARDIAC; RIBONUCLEOPROTEINS; RNA; RNA, SMALL CYTOPLASMIC;

EID: 61649119410     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24358     Document Type: Editorial

References (13)

1. 2-glycoprotein I on apoptotic cells. Arthritis Rheum 2009;60:860-9.
2. Lockshin MD. Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997;277:1549-51.
3. O'Brien CA, Wolin SL. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 1994;8:2891-903.
4. Stein AJ, Fuchs G, Fu C, Wolin SL, Reinisch KM. Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity. Cell 2005;121:529-39.
5. Fuchs G, Stein AJ, Fu C, Reinisch KM, Wolin SL. Structural and biochemical basis for misfolded RNA recognition by the Ro autoantigen. Nat Struct Mol Biol 2006;13:1002-9.
6. Chen X, Smith JD, Shi H, Yang DD, Flavell RA, Wolin SL. The Ro autoantigen binds misfolded U2 small nuclear RNAs and assists mammalian cell survival after UV irradiation. Curr Biol 2003;13:2206-11.
7. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
8. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casiano CA, Di Donato F, et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998;161:5061-9.
9. Reed JH, Neufing PJ, Jackson MW, Clancy RM, Macardle PJ, Buyon JP, et al. Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes. Clin Exp Immunol 2007;148:153-60.
10. Clancy RM, Neufing PJ, Zheng P, O'Mahony M, Nimmerjahn F, Gordon TP, et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006;116:2413-22.
11. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004;50:173-82.
12. Wang MX, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, et al. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995;155:1629-36.
13. 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005;105:1540-5.